Drugs / Combivent Respimat
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | COMBIVENT RESPIMAT | — | 2011-10-07 | fda.gov ↗ |
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01969539 Background | Oct 2013 → Nov 2014 | chronic obstructive pulmonary disease | Boehringer Ingelheim | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Combivent Respimat | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01969539 ↗ |